Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Sep. 30, 2022
Current Assets:
Cash and cash equivalents	$ 19,180	$ 18,998
Accounts receivable, net of allowances of $201 and $81 as of March 31, 2023 and September 30, 2022, respectively	12,120	10,452
Contract assets — royalties and license fees	7,866	7,116
Inventories, net	13,767	11,819
Income tax receivable		2,438
Prepaids and other	8,311	6,764
Total Current Assets	61,244	57,587
Property and equipment, net	27,614	27,148
Intangible assets, net	28,726	28,145
Goodwill	43,823	40,710
Other assets	4,756	4,769
Total Assets	166,163	158,359
Current Liabilities:
Accounts payable	3,788	3,136
Accrued liabilities:
Compensation	5,533	8,929
Accrued other	6,463	5,854
Short-term borrowings		10,000
Deferred revenue	3,346	4,160
Total Current Liabilities	19,130	32,079
Long-term debt, net	29,303
Deferred revenue, less current portion	3,409	5,088
Deferred income taxes	2,025	2,027
Other long-term liabilities	9,742	10,773
Total Liabilities	63,609	49,967
Commitments and Contingencies (Note 11)
Stockholders’ Equity:
Series A Preferred stock - $.05 par value, 450 shares authorized; no shares issued and outstanding
Common stock - $.05 par value, 45,000 shares authorized; 14,134 and 14,029 shares issued and outstanding as of March 31, 2023 and September 30, 2022, respectively	707	701
Additional paid-in capital	32,446	28,774
Accumulated other comprehensive loss	(3,814)	(9,874)
Retained earnings	73,215	88,791
Total Stockholders’ Equity	102,554	108,392
Total Liabilities and Stockholders’ Equity	$ 166,163	$ 158,359